USP13 and ovarian cancer: Our previous study demonstrated that the depletion of USP13 selectively killed the USP13-highly expressing ovarian cancer cells and suppressed ovarian tumor growth in vivo, suggesting an oncogenic addictive phenotype of USP13-amplified ovarian cancer cells [12].